CPT code 67505 denotes a retrobulbar alcohol injection — a neurolytic procedure that delivers alcohol into the space behind the eye to relieve severe ocular pain. The code captures a targeted interventional approach used when other pain-control measures are insufficient or when diagnostic and therapeutic goals require chemical neurolysis. Nationally, the code is relevant to ophthalmology, pain management, and palliative care because it affects procedural authorization, site-of-service decisions, and payer coverage policies for low-volume but high-impact pain interventions.

Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical intent and typical care setting for the procedure, plus coverage and billing considerations relevant to these major payers. The publication outlines benchmarks and policy elements that influence reimbursement, common billing modifiers and coding practices, and the clinical context in which the procedure is used. Data not available in the input is noted where applicable.

This summary is intended for providers, billing professionals, and policy analysts seeking a national-level briefing on the procedural definition, payer landscape, and reporting considerations associated with CPT code 67505.